I 
117TH CONGRESS 
1ST SESSION H. R. 4278 
To direct the Comptroller General of the United States to conduct a study 
on how direct-to-consumer pharmaceutical advertising negatively impacts 
drug costs to consumers, and for other purposes. 
IN THE HOUSE OF REPRESENTATIVES 
JUNE 30, 2021 
Mr. MURPHY of North Carolina (for himself and Mrs. HARSHBARGER) intro-
duced the following bill; which was referred to the Committee on Energy 
and Commerce 
A BILL 
To direct the Comptroller General of the United States to 
conduct a study on how direct-to-consumer pharma-
ceutical advertising negatively impacts drug costs to con-
sumers, and for other purposes. 
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled, 
2
SECTION 1. GAO STUDY ON HOW DIRECT-TO-CONSUMER 
3
PHARMACEUTICAL 
ADVERTISING 
NEGA-
4
TIVELY 
IMPACTS 
DRUG 
COSTS 
TO 
CON-
5
SUMERS. 
6
(a) IN GENERAL.—Not later than 180 days after the 
7
date of the enactment of this Act, the Comptroller General 
8
VerDate Sep 11 2014 
19:33 Jul 26, 2021
Jkt 019200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\H4278.IH
H4278
pamtmann on DSKBC07HB2PROD with BILLS
2 
•HR 4278 IH
of the United States shall conduct a study on how direct- 
1
to-consumer pharmaceutical advertising negatively im-
2
pacts drug costs to consumers. Such study shall focus 
3
on— 
4
(1) what steps may be taken by pharmaceutical 
5
drug manufacturers and distributors to reduce the 
6
higher drug costs paid by consumers as a result of 
7
such advertising by splitting the cost of advertising 
8
between each organization developing a particular 
9
drug; 
10
(2) the expectations of consumers and patients 
11
with respect to the drugs so advertised; and 
12
(3) the role such advertisements play in pro-
13
moting medication to patients for whom such medi-
14
cation may not be necessary. 
15
(b) REPORT.—The Comptroller General shall— 
16
(1) submit a report containing the results of 
17
the study to— 
18
(A) the Committee on the Judiciary and 
19
the Committee on Energy and Commerce of the 
20
House of Representatives; and 
21
(B) the Committee on the Judiciary and 
22
the Committee on Health, Education, Labor, 
23
and Pensions of the Senate; and 
24
VerDate Sep 11 2014 
19:33 Jul 26, 2021
Jkt 019200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\H4278.IH
H4278
pamtmann on DSKBC07HB2PROD with BILLS
3 
•HR 4278 IH
(2) make such report publicly available. 
1
Æ 
VerDate Sep 11 2014 
19:33 Jul 26, 2021
Jkt 019200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6301
E:\BILLS\H4278.IH
H4278
pamtmann on DSKBC07HB2PROD with BILLS
